No Data
No Data
Here's Why Axcelis Technologies (ACLS) Gained But Lagged the Market Today
Top 3 Tech Stocks That Could Blast Off In Q4
Express News | Shares of Semiconductor Companies Are Trading Lower Amid Overall Market Weakness Following the Fed's Rate Decision to Cut Rates by 25 Basis Points
Worst Performing Stocks for Tax Loss Selling – Wolfe
BofA Adjusts Price Target on Axcelis Technologies to $86 From $100, Keeps Neutral Rating
BofA Securities Maintains Axcelis Technologies(ACLS.US) With Hold Rating
72623473 : No use, internal personnel will deliberately create various troubles! Such as fire, such as leaking, and so on... Then they bottom out! Full of routines...
Steven J : I bought $Concentrix (CNXC.US)$ ,$Advanced Micro Devices (AMD.US)$ at these low levels. Sold my $Axcelis Technologies (ACLS.US)$ at 136. I like that one too. But here one of my favorite and is very undervalued $Certara (CERT.US)$ and unappreciated by wallstreet.
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. The pipeline of getting drugs approved keeps going up and Biosimulation should be beneficiary. Do your own Homework